Product Information
NEVIRAPINE 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1314 per EA under NDC 65862002760. Its NADAC has been published 444 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862002760
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
NEVIRAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077521On Market Since
5/22/2012
Pharmacological Classes
Price Statistics
The NADAC for NEVIRAPINE 200 MG TABLET has been published 444 times since Nov 28, 2013, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1314 per EA |
|---|---|
| All-time high | $0.2469 (Sep 13, 2017) |
| All-time low | $0.1122 (Jul 17, 2024) |
| 52-week high | $0.1314 |
| 52-week low | $0.1217 |
| Median price | $0.1508 |
| Average price | $0.1513 |
| Largest weekly change | +45.1% (Jul 18, 2018) |
| Weeks tracked | 444 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEVIRAPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEVIRAPINE 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1314 per EA (NDC 65862002760), effective Aug 20, 2025.
How has the price of NEVIRAPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEVIRAPINE 200 MG TABLET has declined 28.7%. It has been tracked across 444 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEVIRAPINE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for NEVIRAPINE 200 MG TABLET has ranged from a low of $0.1122 (Jul 17, 2024) to a high of $0.2469 (Sep 13, 2017), with a median of $0.1508 per EA.
Are there cheaper alternatives to NEVIRAPINE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as NEVIRAPINE 200 MG TABLET, but none are currently priced below it.
Who manufactures NEVIRAPINE 200 MG TABLET?
NEVIRAPINE 200 MG TABLET (NDC 65862002760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification